Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia

PYRUKYND is currently approved in Europe for adults with PK deficiency; thalassemia would represent its second indication, ...